• 1
    Long E. F., Brandeau M. L., Owens D. K. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 2010; 153: 77889.
  • 2
    Zaric G. S., Barnett P. G., Brandeau M. L. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000; 90: 110011.
  • 3
    National Centre in HIV Epidemiology and Clinical Research (NCHECR). Return on Investment 2: evaluating the cost effectiveness of needle syringe programs in Australia: Department of Health and Ageing. Sydney, Australia: NCHECR; 2009.
  • 4
    National Institute for Health and Clinical Excellence (NICE). Social Value Judgments: Principles for the Development of NICE Guidance, 2nd edn. London: NICE; 2008.